Biomarkers of arsenic exposure and effects in a Canadian rural population exposed through groundwater consumption

Journal of Exposure Science and Environmental Epidemiology

Volumn 24, Issue 2, 2014, Pages 127-134

  Normandin, Louise ^a,b   Ayotte, Pierre ^c   Levallois, Patrick ^c   Ibanez, Yves ^b   Courteau, Marilène ^c   Kennedy, Greg ^d   Chen, Lydia ^e   Le, X Chris ^e   Bouchard, Michèle ^b  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d ÉCOLE POLYTECHNIQUE DE MONTRÉAL   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

arsenic; biological monitoring; drinking water; effect biomarkers; exposure biomarkers; oxidative DNA damage

Indexed keywords

8 OXO 7 HYDRODEOXYGUANOSINE; 8-OXO-7-HYDRODEOXYGUANOSINE; ARSENIC; BIOLOGICAL MARKER; DEOXYGUANOSINE; DRUG DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RURAL POPULATION; URINE; WATER POLLUTANT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ARSENIC; BIOLOGICAL MARKERS; CANADA; DEOXYGUANOSINE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RURAL POPULATION; WATER POLLUTANTS, CHEMICAL; YOUNG ADULT;

EID: 84896730008     PISSN: 15590631     EISSN: 1559064X     Source Type: Journal    
DOI: 10.1038/jes.2013.80     Document Type: Article

References (55)

1. National Research Council. Arsenic in drinking waterNational Academy Press: Washington, DC, 1999.
2. Karagas MR, Stukel TA, Morris JS, Tosteson TD, Weiss JE, Spencer SK et al. Skin cancer risk in relation to toenail arsenic concentrations in a US population-based case-control study. Am J Epidemiol 2001; 153: 559-565.
3. Chen CJ, Chuang YC, You SL, Lin TM, Wu HY. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 1986; 53: 399-405.
4. Chen CL, Chiou HY, Hsu LI, Hsueh YM, Wu MM, Wang YH et al. Arsenic in drinking water and risk of urinary tract cancer: a follow-up study from northeastern Taiwan. Cancer Epidemiol Biomarkers Prev 2010; 19: 101-110.
5. Ferreccio C, Gonzalez C, Milosavjlevic V, Marshall G, Sancha AM, Smith AH. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 2000; 11: 673-679.
6. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Liaw J, Bates M et al. Kidney cancer mortality: fifty-year latency patterns related to arsenic exposure. Epidemiology 2010; 21: 103-108.
7. National Research Council. Arsenic in drinking water-2001 Update. National Academy Press: Washington, DC2001.
8. International Agency for Research on Cancer. Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum Suppl 1987; 7: 1-440.
9. International Agency for Research on Cancer. Some drinking-water disinfectants and contaminants, including arsenic. Summary of data reported and evaluation. IARC Monogr Eval Carcinog Risks Hum 2004; 84: 269-477.
10. U.S. Environmental Protection Agency. National primary drinking water regulations: arsenic and contaminants monitoring. Fed Reg 2001; 66: 6975-7066.
11. Health Canada. Guidelines for Canadian driniking water quality: guideline technical document. Health Canada: Ottawa, Ontario, 2006.
12. World Health Organization. Guidelines for drinking-water quality. First addendum to third edition-Recommendations. World Health Organization: Geneva, Switzerland, 2006.
13. Agency for Toxic Substances and Disease Registry. Toxicological profile for arsenic. US Department of Health and Human Services: Atlanta, GA, 2007
14. Orloff K, Mistry K, Metcalf S. Biomonitoring for environmental exposures to arsenic. J Toxicol Environ Health B Crit Rev 2009; 12: 509-524.
15. Hunter DJ, Morris JS, Chute CG, Kushner E, Colditz GA, Stampfer MJ et al. Predictors of selenium concentration in human toenails. Am J Epidemiol 1990; 132: 114-122.
16. Adair BM, Hudgens EE, Schmitt MT, Calderon RL, Thomas DJ. Total arsenic concentrations in toenails quantified by two techniques provide a useful biomarker of chronic arsenic exposure in drinking water. Environ Res 2006; 101: 213-220.
17. Harkey MR. Anatomy and physiology of hair. Forensic Sci Int 1993; 63: 9-18.
18. Wilhelm M, Idel H. Hair analysis in environmental medicine. Zentralbl Hyg Umweltmed 1996; 198: 485-501.
19. Fleckman P. Anatomy and physiology of the nail. Dermatol Clin 1985; 3: 373-381.
20. Fleckman P. Basic science of the nail unit. In: Scher RK, Daniel CR editors. Nails: therapy, diagnosis, surgery. Philadelphie. W. B. Saunders Company, 1997, p 37-54.
21. Kitchin KT. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol Appl Pharmacol 2001; 172: 249-261.
22. Kitchin KT, Ahmad S. Oxidative stress as a possible mode of action for arsenic carcinogenesis. Toxicol Lett 2003; 137: 3-13.
23. Cerutti PA. Oxy-radicals and cancer. Lancet 1994; 344: 862-863.
24. Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009; 27: 120-139.
25. Yamauchi H, Aminaka Y, Yoshida K, Sun G, Pi J, Waalkes MP. Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicol Appl Pharmacol 2004; 198: 291-296.
26. Fujino Y, Guo X, Liu J, Matthews IP, Shirane K, Wu K et al. Chronic arsenic exposure and urinary 8-hydroxy-2'-deoxyguanosine in an arsenic-Affected area in Inner Mongolia, China. J Expo Anal Environ Epidemiol 2005; 15: 147-152.
27. Ministère du Développement durable dldlFedPM. Portrait régional de l'eau. Chaudière-Appalaches. Site du MDDEFP, 2002. Available from: http://www. mddep.gouv.qc.ca/eau/regions/region12/12- chaudiere(suite).htm#51.
28. Ministère des Ressources naturelles et de la Faune E-sigeom à la carte. Base de données géoscientifiques. Government of Quebec, Quebec, Canada, 1983. Available from: http://sigeom.mrn.gouv.qc.ca/ signet/classes/I1102-indexAccueil?l=a.
29. Watanabe C, Inaoka T, Kadono T, Nagano M, Nakamura S, Ushijima K et al. Males in rural Bangladeshi communities are more susceptible to chronic arsenic poisoning than females: analyses based on urinary arsenic. Environ Health Perspect 2001; 109: 1265-1270.
30. Kennedy GG. Trace element determination in polymers by neutron activation: metallization of polymersAmerican Chemical Society: Montré al, 1990.
31. Foster H, Kennedy G, Maisonneuve P, Krewski D, Ghadirian P. A case-control study of toenail selenium, mercury, arsenic and cadmium and cancer of the breast, colon and prostate in Montreal. Trends Cancer Res 2008; 4: 15-18.
32. Le XC, Ma M, Cullen WR, Aposhian HV, Lu X, Zheng B. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect 2000; 108: 1015-1018.
33. Jaffé M, Hoppe Seyler's Z. Physiol Chem 1886; 10: 391-400.
34. Dabeka RW, McKenzie AD, Lacroix GM, Cleroux C, Bowe S, Graham RA et al. Survey of arsenic in total diet food composites and estimation of the dietary intake of arsenic by Canadian adults and children. J AOAC Int 1993; 76: 14-25.
35. Uneyama C, Toda M, Yamamoto M, Morikawa K. Arsenic in various foods: cumulative data. Food Addit Contam 2007; 24: 447-534.
36. World Health Organization. Biological monitoring of chemical exposure in the workplaceWorld Health Organization: Genè ve, 1996.
37. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005; 113: 192-200.
38. Karagas MR, Morris JS, Weiss JE, Spate V, Baskett C, Greenberg ER. Toenail samples as an indicator of drinking water arsenic exposure. Cancer Epidemiol Biomarkers Prev 1996; 5: 849-852.
39. Karagas MR, Tosteson TD, Blum J, Klaue B, Weiss JE, Stannard V et al. Measurement of low levels of arsenic exposure: a comparison of water and toenail concentrations. Am J Epidemiol 2000; 152: 84-90.
40. Slotnick MJ, Meliker JR, AvRuskin GA, Ghosh D, Nriagu JO. Toenails as a biomarker of inorganic arsenic intake from drinking water and foods. J Toxicol Environ Health A 2007; 70: 148-158.
41. Slotnick MJ, Meliker JR, Nriagu JO. Intra-individual variability in toenail arsenic concentrations in a Michigan population, USA. J Expo Sci Environ Epidemiol 2008; 18: 149-157.
42. Button M, Jenkin GR, Harrington CF, Watts MJ. Human toenails as a biomarker of exposure to elevated environmental arsenic. J Environ Monit 2009; 11: 610-617.
43. Kile ML, Houseman EA, Rodrigues E, Smith TJ, Quamruzzaman Q, Rahman M et al. Toenail arsenic concentrations, GSTT1 gene polymorphisms, and arsenic exposure from drinking water. Cancer Epidemiol Biomarkers Prev 2005; 14: 2419-2426.
44. Rivera-Nunez Z, Meliker JR, Meeker JD, Slotnick MJ, Nriagu JO. Urinary arsenic species, toenail arsenic, and arsenic intake estimates in a Michigan population with low levels of arsenic in drinking water. J Expo Sci Environ Epidemiol 2012; 22: 182-190.
45. Hinwood AL, Sim MR, Jolley D, de Klerk N, Bastone EB, Gerostamoulos J et al. Hair and toenail arsenic concentrations of residents living in areas with high environmental arsenic concentrations. Environ Health Perspect 2003; 111: 187-193.
46. Meza MM, Kopplin MJ, Burgess JL, Gandolfi AJ. Arsenic drinking water exposure and urinary excretion among adults in the Yaqui Valley, Sonora, Mexico. Environ Res 2004; 96: 119-126.
47. Baskett CK, Spate VL, Mason MM, Nichols TA, Williams A, Dubman IM et al. Long term selenium status in humans. Radioanla Nucl Chem 2001; 249: 429-435.
48. Longnecker MP, Stampfer MJ, Morris JS, Spate V, Baskett C, Mason M et al. A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am J Clin Nutr 1993; 57: 408-413.
49. Caldwell KL, Jones RL, Verdon CP, Jarrett JM, Caudill SP, Osterloh JD. Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004. J Expo Sci Environ Epidemiol 2009; 19: 59-68.
50. Lovreglio P, D'Errico MN, De PP, Gilberti ME, Drago I, Panuzzo L et al. Environmental factors affecting the urinary excretion of inorganic arsenic in the general population. Med Lav 2012; 103: 372-381.
51. Gong Z, Lu X, Cullen WR, Le XC. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J Anal At Spectrom 2001; 16: 1409-1413.
52. Del Razo LM, Styblo M, Cullen WR, Thomas DJ. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol 2001; 174: 282-293.
53. Burgess JL, Meza MM, Josyula AB, Poplin GS, Kopplin MJ, McClellen HE et al. Environmental arsenic exposure and urinary 8-OHdG in Arizona and Sonora. Clin Toxicol (Phila) 2007; 45: 490-498.
54. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004; 339: 1-9.
55. Poulsen HE, Loft S, Vistisen K. Extreme exercise and oxidative DNA modification. J Sports Sci 1996; 14: 343-346.